MedTrace Logo

Treatment and Outcomes in Patients With COVID-19 and Competing Acute Surgical Diseases in Moscow

NCT07719166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58000

Last updated 2026-07-22

No results posted yet for this study

Summary

The COVID-19 pandemic has posed a significant challenge to surgical practice. This study aims to investigate the structure of hospitalizations, treatment outcomes, and surgical tactics in patients with COVID-19 and competing different acute surgical diseases (ASD). The research is based on real-world data (RWD) from a large multidisciplinary hospital repurposed as a COVID-19 center. The study analyze the mutual impact of these two acute conditions on patient outcomes, develop prognostic models for in-hospital mortality, and evaluate changes in surgical approaches during the pandemic.

Conditions

  • COVID-19
  • Emergency Surgery
  • Abdominal Surgery
  • Real-World Data

Interventions

PROCEDURE

Surgical and Interventional Management of Acute Surgical Conditions

Surgical and interventional procedures performed as part of routine clinical care for acute surgical conditions, including abdominal, thrombotic, hemorrhagic, infectious, and other surgically significant conditions. Procedures included open and laparoscopic surgery, bowel resection, drainage, debridement, hemostatic procedures, angiography, endovascular embolization, and other condition-specific interventions, as clinically indicated. Treatment was not assigned, standardized, or modified by the study protocol. The type and timing of each procedure and the associated in-hospital and postoperative outcomes were obtained from routine medical records and analyzed across clinical subgroups and the pandemic and post-pandemic periods.

Sponsors & Collaborators

  • Moscow Multidisciplinary Clinical Center "Kommunarka"

    collaborator OTHER_GOV

  • Pirogov Russian National Research Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2024-01-01
Completion
2026-07-01

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07719166 on ClinicalTrials.gov